However, in human breast tumor samples, the transcription level of GAS5 are significantly reduced, which is statistically significant in stage I and II cancers 35, prompting the decrease of GAS5 expression as an early event of tumorigenesis 36. This evidence concerns the gene GAS5 and breast neoplasm.